Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs Xcel Energy Inc (XEL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs Xcel Energy Inc — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $105.11 (market cap $8.87B), while Xcel Energy Inc trades at $76.01 (market cap $46.62B). The key difference: Xcel Energy Inc is far larger — about 5.3× Kymera Therapeutics Inc. Common Stock's market cap, and Xcel Energy Inc pays a 3.18% dividend while Kymera Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and Xcel Energy Inc for 61 Days on average.
| KYMR | XEL | |
|---|---|---|
Market Cap | $8.87B | $46.62B |
Volume | 779,107 | 4,168,668 |
Sector | Health | Utilities |
52-Week High | $127.31 | $83.91 |
52-Week Low | $55.80 | $69.39 |
Typical Hold Time | 0 Days | 61 Days |
Enterprise Value | $8.26B | $84.94B |
Dividend Yield | — | 3.18% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Xcel Energy (XEL) trades at $75.36, up 1.6% on the day, with a bullish technical signal and strong analyst consensus. Recent earnings show mixed results with a Q2 2026 beat (EPS $0.93 vs. $0.79 expected) but a Q4 2025 miss. Revenue for 2025 was $14.67B with a net income margin of 15.28%, while the company maintains a P/E of 20.45 and ROE of 9.92%. News highlights include partnerships for electric school buses and growth from data center power demand.
The outlook is positive, supported by a $60 billion capital expenditure plan and rising power demand, offering potential upside to the $90.58 consensus price target. Key risks include wildfire liabilities, high debt levels, and regulatory scrutiny. The stock presents a balanced opportunity for income and growth investors, with a dividend yield around 3.3% and institutional accumulation noted in recent filings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About Xcel Energy Inc
Xcel Energy manages utilities serving 3.7 million electric customers and 2.1 million natural gas customers in eight states. Its utilities are Northern States Power, which serves customers in Minnesota, North Dakota, South Dakota, Wisconsin, and Michigan
Read more on XEL →
